Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Centre Euopéen de Recherche et de Formation Avancée en Calcul Scientifique (CERFACS)
- Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P.
- Eindhoven University of Technology (TU/e)
- Heidelberg University
- KINGS COLLEGE LONDON
- NTNU Norwegian University of Science and Technology
- Technical University of Munich
- Universitat de Barcelona
- University of Southern Denmark
-
Field
-
Per Week 38 Offer Starting Date 1 Oct 2026 Is the job funded through the EU Research Framework Programme? Horizon Europe - MSCA Reference Number 101227259 Marie Curie Grant Agreement Number 101227259 Is
-
. in the graduation class for the study programme. List of publications and maximum 2 examples of relevant publications (in case you have any publications). References may be included, you're welcome
-
Framework Programme? Not funded by a EU programme Reference Number CNS2023-145425 Is the Job related to staff position within a Research Infrastructure? No Offer Description Descifrando la vulnerabilidad
-
Norway Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research
-
) The Institute of Computer Engineering (ZITI) at Heidelberg University invites applications for one research assistant position with the possibility to do a PhD in parallel at the chair of computer architecture
-
Centre Euopéen de Recherche et de Formation Avancée en Calcul Scientifique (CERFACS) | Toulouse, Midi Pyrenees | France | about 2 months ago
Research Framework Programme? Horizon Europe - MSCA Is the Job related to staff position within a Research Infrastructure? No Offer Description About SLICE Space utilisation plays a crucial role in
-
Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No Offer Description Are you an engineer who wants to contribute to the high
-
technologies, drug discovery and advanced therapeutics. We have excellent facilities to support our parallel use of pre-clinical cell and in vivo models, alongside human cellular models, which provide
-
systems involved in an effective health care system, rather than creating new medical treatments. Our recent studies have been motivated by two parallel questions: How can we encourage people to engage with